EXTL3 could serve as a potential biomarker of prognosis and immunotherapy for prostate cancer and its potential mechanisms

por Chang, Pingan, Chen, Shenglan, Chang, Xiumei, Zhu, Jiaxi, Tang, Qingsheng, Ma, Limin
Publicado 2022